- Home
- JAZZ vs EDR Comparison
JAZZ vs EDR Comparison
Compare JAZZ & EDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- EDR
- Stock Information
- Founded
- JAZZ 2003
- EDR 2009
- Country
- JAZZ Ireland
- EDR United States
- Employees
- JAZZ N/A
- EDR 10000
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- EDR Services-Misc. Amusement & Recreation
- Sector
- JAZZ Health Care
- EDR Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- EDR Nasdaq
- Market Cap
- JAZZ 8.4B
- EDR 9.5B
- IPO Year
- JAZZ 2007
- EDR 2021
- Fundamental
- Price
- JAZZ $122.92
- EDR N/A
- Analyst Decision
- JAZZ Strong Buy
- EDR Hold
- Analyst Count
- JAZZ 13
- EDR 8
- Target Price
- JAZZ $187.15
- EDR $27.81
- AVG Volume (30 Days)
- JAZZ 1.3M
- EDR 1.2M
- Earning Date
- JAZZ 04-30-2025
- EDR 05-08-2025
- Dividend Yield
- JAZZ N/A
- EDR 0.83%
- EPS Growth
- JAZZ 41.75
- EDR N/A
- EPS
- JAZZ 8.65
- EDR N/A
- Revenue
- JAZZ $4,068,950,000.00
- EDR $7,110,982,000.00
- Revenue This Year
- JAZZ $7.30
- EDR N/A
- Revenue Next Year
- JAZZ $4.01
- EDR $15.54
- P/E Ratio
- JAZZ $14.21
- EDR N/A
- Revenue Growth
- JAZZ 6.12
- EDR 29.51
- 52 Week Low
- JAZZ $99.06
- EDR $24.41
- 52 Week High
- JAZZ $148.06
- EDR $35.99
- Technical
- Relative Strength Index (RSI)
- JAZZ 32.69
- EDR 6.47
- Support Level
- JAZZ $137.74
- EDR $28.56
- Resistance Level
- JAZZ $142.64
- EDR $29.60
- Average True Range (ATR)
- JAZZ 3.87
- EDR 0.32
- MACD
- JAZZ -2.12
- EDR -3.31
- Stochastic Oscillator
- JAZZ 0.45
- EDR 0.00
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About EDR Endeavor Group Holdings Inc.
Endeavor Group Holdings Inc is an entertainment and sports company. The company owns and operates sports and entertainment properties, including UFC and WWE through its majority ownership of TKO, produces and distributes sports and entertainment content, owns and manages exclusive live events and experiences, and represents top sports, entertainment, and fashion talent, as well as blue chip corporate clients. Its reportable segments are Owned Sports Properties, Events, Experiences & Rights, and Representation. Maximum revenue is generated from its Owned Sports Properties segment, which is comprised of a portfolio of sports and entertainment properties, including UFC, WWE, PBR, and Euroleague. Geographically, it derives key revenue from the United States.